Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics

J. Kuschill-Dziurda, G. Bochenek, D. Dziurda, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland)

Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Session: Asthma aspect of diagnosis and criteria for follow-up
Session type: Thematic Poster Session
Number: 523
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Kuschill-Dziurda, G. Bochenek, D. Dziurda, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland). Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics. Eur Respir J 2010; 36: Suppl. 54, 523

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical and histological impact of omalizumab in oral corticosteroid-dependent severe allergic asthma
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019



Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008


The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Treating rhinitis in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006

Airways inflammation is related to bronchial responsiveness only in atopic subjects with rhinitis and/or asthma
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008

Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

Treatment and outcomes in patients with asthma and allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009

Association of asthma control with allergic rhinitis severity in adult patients
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019

Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 121s
Year: 2006

The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019


Clinical efficacy of leukotriene antagonist in patients with asthma and allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005

Refining asthma treatment for mild asthma
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020